Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The ACR’s State-of-the-Art Clinical Symposium: Rheumatologists Weigh in on Tough-to-Treat Cases, Paget’s Disease, Imaging

Thomas R. Collins  |  Issue: July 2015  |  July 14, 2015

This treatment regimen was followed by a course of IV pamidronate, which did reduce bone turnover markers by 50%. Over the ensuing months, though, the levels of biomarkers quickly rose again. Pamidronate resistance has been reported with repeated cycles. When the patient’s urine N-terminal telopeptide and serum alkaline phosphatase continued to rise to levels matching those at presentation, the patient was treated with 4 mg of zoledronic acid by infusion, which normalized bone turnover markers.

Dr. Seton

Dr. Seton

Zoledronic acid, Dr. Seton said, “is very effective therapy for Paget’s disease. It’s even very effective in patients who have failed other bisphosphonates.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Although studies have shown that zoledronic acid—now approved for Paget’s disease at a 5 mg dose—can result in a sustained biochemical remission of 6.5 years or longer, long-term outcomes may not differ in patients who have been treated aggressively to normalize the serum alkaline phosphatase compared with those patients treated symptomatically.4 This may be due to the nature of the patients treated and captured in this study, for example, those with long-term disease and coexisting morbidities, she said.

“My own interpretation is that they’ve remodeled bone to such an extent that maybe it’s too much to ask of a drug, at the age of 80, to change that [outcome].”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Imaging

With so many ways to image patients now available, the choices of which to use have become more complicated, said Imran Omar, MD, chief of musculoskeletal radiology at the Northwestern University Feinberg School of Medicine, Chicago. Each modality has strengths and drawbacks that can help guide their use, he said.

Clinicians should always start with radiographs because, with well-established patterns of disease, X-rays can give an accurate diagnosis in a lot of patients. They are also highly reproducible and inexpensive.

On the other hand, X-rays are fairly insensitive to bony erosions, soft tissues cannot be seen very well, and they expose patients to radiation, Dr. Omar said.

MRI, with excellent spatial and contrast resolution and clear depictions of anatomy, is frequently used to assess active disease and the extent of disease. But they’re expensive and uncomfortable for some patients.

CT imaging often results in findings similar to X-rays, but soft tissue can be seen more clearly and cross-sectional images can be used to localize findings more accurately.

At his center, CT is often used as a problem-solving tool, Dr. Omar said. “If there is a question on radiography or another imaging study, such as MRI, we often will go to CT,” he said.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsMeeting Reports Tagged with:combination therapydrugimagingoutcomePaget’s diseasepatient careRheumatic Diseaserheumatologisttoxicity

Related Articles
    Set Realistic Career Goals to Reach Your Professional Potential

    Set Realistic Career Goals to Reach Your Professional Potential

    January 19, 2016

    As a rheumatologist, you’re used to having goals. After all, you set your sights on becoming a physician, achieved the necessary educational degrees and passed required exams. After meeting your educational goals, you landed a job at an academic medical center or an established rheumatology practice, or you may have started your own practice. So…

    A Duet of Bone and the Immune System

    July 12, 2011

    Examining emerging perspectives in osteoimmunology

    Meet the HEP C Challenge

    December 1, 2008

    Keep a hepatitis C virus infection from hindering RA treatment

    Paget’s Disease of Bone

    May 1, 2007

    Paget’s disease generally affects people over 40, and while the disease is associated with heredity, the cause is unknown. The ACR has recently added a fact sheet about this condition to the patient education material online.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences